Heterojunction photocatalyst for the degradation and mineralization of pharmaceutical effluent: Clozapine

A research paper titled “Robust visible light active PANI/LaFeO3/CoFe2O4 ternary heterojunction for the photo-degradation and mineralization of pharmaceutical effluent: Clozapine” has been published by Dr Lakhveer Singh from the Department of Environmental Science at SRM University – AP, as a co-author, in Journal of Environmental Chemical Engineering, having an Impact Factor of 5.90.

Clozapine (CZP) is a second-generation antipsychotic medicine prescribed for the treatment of resistant schizophrenia. The reported side effects of CZP includes cardiometabolic, orthostatic hypotension, tachycardia, seizures, myocarditis, weight gain and obesity. In this research, a novel magnetic ternary PANI/LaFeO3/CoFe2O4 (PLC) heterojunction photocatalyst was developed for the degradation and mineralization of pharmaceutical effluent: Clozapine. The photocatalysts were found to be re-usable for 5 consecutive cycles.

This work has been in collaboration with Central University Jammu. The present study has a new insight into the development and fabrication of efficient ternary heterojunction towards promising application prospects in wastewater remediation.

Dr Lakhveer Singh is an Editorial Board member of the Journal of Biomass Conversion and Biorefinery – Springer (I.F. 2.60) and a Guest Editor for Bioresource Technology Reports- Elsevier.

Read the full paper here: https://doi.org/10.1016/j.jece.2021.106159

Leave a Reply

Your email address will not be published. Required fields are marked *